Comparative genomics revealed key molecular targets to rapidly convert a reference rifamycin-producing bacterial strain into an overproducer by genetic engineering.

Metab Eng 2014 Nov 19;26:1-16. Epub 2014 Aug 19.

Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce 73100, Italy. Electronic address:

Rifamycins are mainstay agents in treatment of many widespread diseases, but how an improved rifamycin producer can be created is still incompletely understood. Here, we describe a comparative genomic approach to investigate the mutational patterns introduced by the classical mutate-and-screen method in the genome of an improved rifamycin producer. Comparing the genome of the rifamycin B overproducer Amycolatopsis mediterranei HP-130 with those of the reference strains A. mediterranei S699 and U32, we identified 250 variations, affecting 227 coding sequences (CDS), 109 of which were HP-130-specific since they were absent in both S699 and U32. Mutational and transcriptional patterns indicated a series of genomic manipulations that not only proved the causative effect of mutB2 (coding for methylmalonyl-CoA mutase large subunit) and argS2 (coding for arginyl tRNA synthetase) mutations on the overproduction of rifamycin, but also constituted a rational strategy to genetically engineer a reference strain into an overproducer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymben.2014.08.001DOI Listing
November 2014
21 Reads

Publication Analysis

Top Keywords

improved rifamycin
8
rifamycin producer
8
strain overproducer
8
s699 u32
8
mutational patterns
4
transcriptional patterns
4
investigate mutational
4
patterns indicated
4
mutational transcriptional
4
u32 mutational
4
absent s699
4
introduced classical
4
approach investigate
4
patterns introduced
4
genomic approach
4
understood describe
4
manipulations proved
4
incompletely understood
4
proved causative
4
describe comparative
4

Similar Publications